• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物标志物和超声心动图在接受白血病治疗的儿童心脏毒性风险评估中的作用。

The role of biomarkers and echocardiography in the evaluation of cardiotoxicity risk in children treated for leukemia.

作者信息

Raluca Maniu Diana, Blag Cristina, Popa Gheorghe, Bota Madalina, Vlad Catalin, Cainap Calin, Balacescu Ovidiu, Pop Laura, Cainap Simona Sorana

机构信息

Emergency County Hospital for Children, Pediatric Clinic no 2, Department of Pediatric Cardiology, Cluj-Napoca, Romania.

出版信息

J BUON. 2018 Dec;23(7):122-131.

PMID:30722121
Abstract

PURPOSE

To describe the high-risk profile group, susceptible to develop anthracycline-induced cardiomyopathy in children with acute leukemia.

METHODS

The study involved 35 pediatric patients diagnosed with acute lymphoblastic (ALL) or acute myeloblastic leukemia (AML), from March 2014 to December 2016. Serologic markers used for the analysis of cardiac dysfunction were troponin T, NT-proBNP and PCRhs. Also, the patients have had echocardiographic evaluation at the beginning of treatment to determine LVEF, SF and A, E, E' Doppler waves.

RESULTS

Positive linear correlation was shown between NT-proBNP and leukocyte values, NT-proBNP and blast cells value, and NT-proBNP and LDH. Significant linear negative correlations between LVEF with leukocyte values, blast cells values, LDH, SF and leukocyte values, LVEF and NT-proBNP values and LVEF and troponin T values were also identified. A weak negative correlation between E/E' ratio and blast cells values has been observed. All of these correlations were statistically significant (p<0.05).

CONCLUSIONS

Leukocyte value, as well as the other serological markers assessed (NT-proBNP, Troponin T), are useful tools to evaluate the risk of anthracycline-induced cardiotoxicity. The variation of the biological markers at the beginning of the cytotoxic treatment confirms the presence of an early myocardial dysfunction, emphasizing the importance of systematic evaluation of this particular group of patients.

摘要

目的

描述急性白血病患儿中易发生蒽环类药物诱导性心肌病的高危人群特征。

方法

该研究纳入了2014年3月至2016年12月期间诊断为急性淋巴细胞白血病(ALL)或急性髓细胞白血病(AML)的35例儿科患者。用于分析心脏功能障碍的血清学标志物为肌钙蛋白T、N末端脑钠肽前体(NT-proBNP)和高敏C反应蛋白(PCRhs)。此外,患者在治疗开始时进行了超声心动图评估,以确定左心室射血分数(LVEF)、缩短分数(SF)以及A、E、E' 多普勒波。

结果

NT-proBNP与白细胞值、NT-proBNP与原始细胞值以及NT-proBNP与乳酸脱氢酶(LDH)之间呈正线性相关。还发现LVEF与白细胞值、原始细胞值、LDH、SF与白细胞值、LVEF与NT-proBNP值以及LVEF与肌钙蛋白T值之间存在显著的线性负相关。观察到E/E' 比值与原始细胞值之间存在弱负相关。所有这些相关性均具有统计学意义(p<0.05)。

结论

白细胞值以及评估的其他血清学标志物(NT-proBNP、肌钙蛋白T)是评估蒽环类药物诱导的心脏毒性风险的有用工具。细胞毒性治疗开始时生物标志物的变化证实了早期心肌功能障碍的存在,强调了对这一特定患者群体进行系统评估的重要性。

相似文献

1
The role of biomarkers and echocardiography in the evaluation of cardiotoxicity risk in children treated for leukemia.生物标志物和超声心动图在接受白血病治疗的儿童心脏毒性风险评估中的作用。
J BUON. 2018 Dec;23(7):122-131.
2
Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.蒽环类药物治疗急性淋巴细胞白血病(ALL)期间和治疗后不久的儿童心肌 2 维应变超声心动图和心脏生物标志物:一项前瞻性研究。
Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):562-9. doi: 10.1093/ehjci/jes217. Epub 2012 Oct 29.
3
Assessment of anthracycline-induced cardiotoxicity with biochemical markers.用生物化学标志物评估蒽环类药物引起的心脏毒性。
Exp Oncol. 2007 Dec;29(4):309-13.
4
N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.N端前B型利钠肽作为儿童急性蒽环类药物心脏毒性的标志物。
J Pediatr Hematol Oncol. 2007 Jul;29(7):440-4. doi: 10.1097/MPH.0b013e3180640d42.
5
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens.曲妥珠单抗联合蒽环类药物治疗乳腺癌患者心脏生物标志物的药效动力学建模。
J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):431-442. doi: 10.1007/s10928-018-9579-8. Epub 2018 Feb 10.
6
Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.NT-proBNP 在检测接受和未接受蒽环类药物治疗的儿童白血病幸存者心肌损伤中的作用。
J Exp Clin Cancer Res. 2012 Oct 11;31(1):86. doi: 10.1186/1756-9966-31-86.
7
The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.生物化学标志物在白血病治疗患者心脏毒性监测中的应用。
Neoplasma. 2005;52(5):430-4.
8
Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.儿童迟发性蒽环类药物诱导的心脏毒性的生物标志物与早期检测
Hematology. 2012 May;17(3):151-6. doi: 10.1179/102453312X13376952196412.
9
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.多柔比星治疗高危儿童急性淋巴细胞白血病患者期间心脏生物标志物的变化:与长期超声心动图结果的关系。
J Clin Oncol. 2012 Apr 1;30(10):1042-9. doi: 10.1200/JCO.2010.30.3404. Epub 2012 Feb 27.
10
Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.急性白血病预处理方案及造血细胞移植期间心脏毒性的生化标志物与评估
Exp Oncol. 2007 Sep;29(3):243-7.

引用本文的文献

1
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.复发或难治性急性髓系白血病成年患者的心脏毒性
Cancers (Basel). 2025 Jul 22;17(15):2413. doi: 10.3390/cancers17152413.
2
Exploring the baseline cardiac function and its correlation with risk stratification in children diagnosed with acute lymphoblastic leukemia.探索初诊急性淋巴细胞白血病患儿的基线心脏功能及其与危险分层的相关性。
Ann Hematol. 2025 Aug;104(8):4157-4164. doi: 10.1007/s00277-025-06523-7. Epub 2025 Jul 30.
3
Shenmai Injection Reduces Cardiomyocyte Apoptosis Induced by Doxorubicin through miR-30a/Bcl-2.
参麦注射液通过miR-30a/Bcl-2减轻阿霉素诱导的心肌细胞凋亡。
Chin J Integr Med. 2025 Mar;31(3):240-250. doi: 10.1007/s11655-025-4005-8. Epub 2025 Jan 15.
4
Differential cardiac impacts of hematological malignancies and solid tumors: a histopathological and biomarker study.血液系统恶性肿瘤和实体瘤对心脏的不同影响:一项组织病理学和生物标志物研究。
Cardiooncology. 2024 Dec 19;10(1):90. doi: 10.1186/s40959-024-00285-3.
5
High NT pro-BNP levels in children with malignant disorder receiving intensive fluid treatment: a prospective comparative study.接受强化液体治疗的恶性疾病患儿中高NT-proBNP水平:一项前瞻性比较研究。
Front Pediatr. 2024 Nov 27;12:1408231. doi: 10.3389/fped.2024.1408231. eCollection 2024.
6
Anthracycline's Effects on Heart Rate Variability in Children with Acute Lymphoblastic Leukemia: Early Toxicity Signs-Pilot Study.蒽环类药物对急性淋巴细胞白血病患儿心率变异性的影响:早期毒性体征——初步研究
J Clin Med. 2023 Nov 12;12(22):7052. doi: 10.3390/jcm12227052.
7
Assessment of left heart dysfunction to predict doxorubicin cardiotoxicity in children with lymphoma.评估左心功能不全以预测淋巴瘤患儿的阿霉素心脏毒性。
Front Pediatr. 2023 May 5;11:1163664. doi: 10.3389/fped.2023.1163664. eCollection 2023.
8
High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications.高敏肌钙蛋白:特征、评估及临床意义的综述。
Dis Markers. 2022 Mar 28;2022:9713326. doi: 10.1155/2022/9713326. eCollection 2022.
9
Cardiotoxicity of chemotherapy and targeted agents.化疗及靶向药物的心脏毒性
Am J Cancer Res. 2021 Apr 15;11(4):1132-1147. eCollection 2021.
10
Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis.贝伐珠单抗联合伊立替康作为转移性结直肠癌一线治疗可提高无进展生存期:一项回顾性分析。
PLoS One. 2021 Apr 28;16(4):e0248922. doi: 10.1371/journal.pone.0248922. eCollection 2021.